Study: Testosterone Therapy Might Slow Diabetes Progress
Both prediabetes and low testosterone levels can increase a man's risk for developing type 2 diabetes. However, undergoing testosterone therapy might help, according to a recent Diabetes Care study.
Prediabetes is diagnosed when a person's blood sugar levels are higher than normal, but not high enough to be diagnosed with diabetes.
For eight years, researchers followed the progress of 316 men. At the start of the study, all of the men had both prediabetes and low testosterone (also called hypogonadism).
Two hundred twenty-nine men underwent testosterone therapy, but the rest did not. The researchers monitored the men's health status regularly.
By the end of the study, 90% of the men who had taken testosterone had normal blood sugar levels again. However, 40% of the men in the untreated group had developed type 2 diabetes.
To learn more about prediabetes, low testosterone, and the study, please click here.
Peyronie's Disease: Injection Therapies Compared
Men with Peyronie's disease have several treatment options available, depending on the severity of their condition.
Peyronie's disease is marked by plaques that form on the penis, just below the skin's surface. These areas of hardened scar tissue make the penis less flexible and cause it to bend.
For some men, intralesional injections - medicine delivered directly into the plaques - is the most appropriate treatment choice. Several different drugs can be used for this purpose.
In a new Journal of Sexual Medicine review, experts analyzed the effectiveness of four intralesional injection drugs: Collagenase Clostridium histolyticum (CCH), hyaluronic acid, verapamil, and interferon α-2b.
Which drug worked best? The answer may depend on the patient's treatment priorities, the authors said.
Here's what they discovered.
|